U.S. Federal Issues

FDA Authority over Tobacco:
Regulatory Documents

Comments Submitted to the FDA by Campaign for Tobacco-Free Kids and Partners

Public Health and Medical Groups Letter to FDA on Tobacco Product Standards (March 27, 2014)

Campaign for Tobacco-Free Kids Letter to FDA on Canadian Warning Label Study (Nov. 25, 2013)

Public Health and Medical Groups Comments on Menthol in Tobacco Products (Nov. 22, 2013)

Campaign for Tobacco Free Kids Comments on Tobacco Product Analysis (Sept. 30, 2013)

Public Health Group Comments on FDA Collection of Tobacco Industry Health Documents (June 10, 2013)

Public health groups Comments on Tobacco Manufacturers’ Submission of Proposed “Good Manufacturing Practices” (May 20, 2013)

Tobacco Control Legal Consortium and Public Health Groups Citizen Petition on Menthol Cigarettes (April 12, 2013)

Public health and medical groups Comments on Smokeless Tobacco Product Warning Statements (April 1, 2013)

Statement of Matthew L. Myers before FDA Third Party Governance of Industry Sponsored Research Tobacco Product Workshop, (March 19, 2013)

Citizen Petition filed by New York City and Public Health Groups to Implement Track and Trace System (March 6, 2013)

Public health groups Comments in Response to Submissions of Other Parties on Demonstrating Substantial Equivalence for Tobacco Product (Jan. 28, 2013)

Campaign for Tobacco-Free Kids Comments on Actions Related to Nicotine Replacement Therapies and Smoking Cessation Products (Jan. 16, 2013)

Public health and medical groups comments to FDA on Petition of R.J. Reynolds Tobacco Company and American Snuff Company for Rulemaking to Adjust Statutory Smokeless Tobacco Warning (Nov. 16, 2012)

Campaign for Tobacco-Free Kids letter to FDA concerning misbranding of roll-your-own tobacco as pipe tobacco (Aug. 3, 2012)

Public Health Groups Comments to FDA on Guidance for Industry on Modified Risk Tobacco Product Applications (June 4, 2012)

Public Health Groups Comments to FDA on proposed collection of information re FDA publication of list of harmful tobacco constituents (Feb. 13, 2012)

Public Health and Medical Groups Comments to FDA on advance notice of proposed rulemaking on non-face-to-face sale and distribution of tobacco products and related promotion and marketing (Jan. 19, 2012)

Public Health and Medical Groups Comments to FDA on Draft Guidance regarding Applications for Premarket Review of New Tobacco Products (Dec. 27, 2011)

Public Health and Medical Groups Comments on Draft Guidance entitled “Demonstrating the Substantial Equivalence of a New Tobacco Product:  Responses to Frequently Asked Questions” (Nov. 8, 2011)

Public Health Groups Comments to FDA on list of harmful and potentially harmful tobacco constituents (Oct. 11, 2011)

Public health and medical groups letter to the FDA regarding large, graphic warning labels on cigarette packs (Jan. 11, 2011)

Campaign for Tobacco-Free Kids letter to the FDA on draft guidance concerning money penalties and no-tobacco-sale orders for tobacco retailers (Oct. 27, 2010)

Public health and medical groups letter to the FDA on the public health impact of dissolvable smokeless tobacco products (Sept. 20, 2010)

Campaign for Tobacco-Free Kids letter to the FDA on tobacco retailer training programs (Sept. 14, 2010)

Campaign for Tobacco-Free Kids letter to the FDA concerning Philip Morris and U.S. Smokeless Tobacco Co. comments on harmful and potentially harmful constituents in tobacco products (Sept. 8, 2010)

Campaign for Tobacco-Free Kids letter to the FDA concerning effective communications about tobacco products and the dangers of tobacco use (Sept. 7, 2010)

Public health groups petition to the FDA requesting that it re-evaluate its approach to reviewing tobacco-cessation products (Aug 26, 2010)

Campaign for Tobacco-Free Kids letter to the FDA on harmful and potentially harmful constituents in tobacco products (Aug. 25, 2010)

Public health and medical groups' letter to the FDA regarding rotational warning plans for smokeless tobacco products (Aug. 5, 2010)

Public health and medical groups' letter to the FDA regarding tobacco industry marketing to youth and racial and ethnic minorities (July 26, 2010)

Public health groups' letter to the FDA regarding outdoor tobacco advertising (July 19, 2010)

Public health groups' letter to the FDA regarding the public health impacts of menthol tobacco products (March 22, 2010)

Public health groups’ letter to the FDA regarding industry efforts to circumvent the "light" and "low" ban (Feb. 18, 2010)

Campaign for Tobacco Free Kids' letter to the FDA regarding penalties for retailers who sell tobacco products to youth under 18 (Jan. 8, 2010)

U.S. Judge Upholds Requirements of FDA Law (Jan. 5, 2010)

Campaign for Tobacco-Free Kids' letter to the FDA regarding smokers' and youths' misperceptions about the gravity of smoking risks (Dec. 28, 2009)

Campaign for Tobacco-Free Kids' letter to the FDA regarding roll-your-own tobacco (Dec. 23, 2009)

Campaign for Tobacco-Free Kids' letter to the FDA summarizing scientific research that supports the new law (Dec. 17, 2009)

Public Health Groups' letter to the FDA regarding tobacco industry disclosure of product ingredients (Nov. 13, 2009)

Public health groups letters to the FDA regarding industry efforts to circumvent the "light" and "low" ban (Sept. 10, 2009)

Public Health Groups' letter to the FDA regarding the ban on flavored cigarettes (Aug. 27, 2009)